Literature DB >> 15180464

Epidemiology of psoriasis.

Luigi Naldi1.   

Abstract

The prevalence of psoriasis is relatively high in the general population, ranging between 0.6% and 4.8%, mainly as a result of chronicity and the absence of a cure. Although genetic-environmental interaction has been proposed as a model for the causation of psoriasis, the evidence for environmental factors is rather scarce. Risk factors, which have been documented in epidemiological studies include smoking, alcohol consumption, diet, infection, drugs, and stressful life events. Psoriasis affects the quality of life to substantial degree. Apart from a few cross-sectional surveys of large series of psoriatic patients, there have been no formal studies of the natural history and prognosis of established psoriasis. By imposing methodologic control and a numerate approach, epidemiology can offer a major contribution to understand psoriasis.

Entities:  

Mesh:

Year:  2004        PMID: 15180464     DOI: 10.2174/1568010043343958

Source DB:  PubMed          Journal:  Curr Drug Targets Inflamm Allergy        ISSN: 1568-010X


  49 in total

1.  Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.

Authors:  Grace K Kim; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2010-01

2.  The relation between different dimensions of alcohol consumption and burden of disease: an overview.

Authors:  Jürgen Rehm; Dolly Baliunas; Guilherme L G Borges; Kathryn Graham; Hyacinth Irving; Tara Kehoe; Charles D Parry; Jayadeep Patra; Svetlana Popova; Vladimir Poznyak; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Benjamin Taylor
Journal:  Addiction       Date:  2010-03-15       Impact factor: 6.526

3.  Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis.

Authors:  Gaku Tsuji; Akiko Hashimoto-Hachiya; Vu Hai Yen; Masaki Takemura; Ayako Yumine; Kazuhisa Furue; Masutaka Furue; Takeshi Nakahara
Journal:  Cell Death Discov       Date:  2020-03-04

4.  Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions.

Authors:  Murat Sunbul; Dilek Seckin; Erdal Durmus; Zuleyha Ozgen; Mehmet Bozbay; Ayfer Bozbay; Tarik Kivrak; Mustafa Oguz; Ibrahim Sari; Tulin Ergun; Mehmet Agirbasli
Journal:  Heart Vessels       Date:  2014-03-15       Impact factor: 2.037

5.  Depression and the risk of psoriasis in US women.

Authors:  P L Dominguez; J Han; T Li; A Ascherio; A A Qureshi
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-03       Impact factor: 6.166

6.  Trends in incidence of adult-onset psoriasis over three decades: a population-based study.

Authors:  Murat Icen; Cynthia S Crowson; Marian T McEvoy; Frank J Dann; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  J Am Acad Dermatol       Date:  2009-03       Impact factor: 11.527

7.  Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study.

Authors:  Amir Hossein Siadat; Fariba Iraji; Mehdi Khodadadi; Maryam Kalateh Jary
Journal:  Adv Biomed Res       Date:  2013-11-30

8.  Potential role of ustekinumab in the treatment of chronic plaque psoriasis.

Authors:  Santo Raffaele Mercuri; Luigi Naldi
Journal:  Biologics       Date:  2010-05-25

9.  A systems model for immune cell interactions unravels the mechanism of inflammation in human skin.

Authors:  Najl V Valeyev; Christian Hundhausen; Yoshinori Umezawa; Nikolay V Kotov; Gareth Williams; Alex Clop; Crysanthi Ainali; Christos Ouzounis; Sophia Tsoka; Frank O Nestle
Journal:  PLoS Comput Biol       Date:  2010-12-02       Impact factor: 4.475

10.  Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.

Authors:  Jochen Schmitt; Gottfried Wozel
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.